V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20160434 | 20061829 | 1.7 | 62.2 | Adjuvant (A) | 2020-05-13 | 2020-06-12 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100531082 |
| 20160435 | 20061830 | 1.84 | 98.3 | Neo-adjuvant (N) | 2017-04-06 | 2017-04-18 | ECX | N | N | ECX | 101541313 |
| 20160438 | 20061831 | 1.75 | 77.5 | Disease modification (D) | 2018-12-29 | 2019-01-12 | ECX | N | N | ECX | 101381827 |
| 20160439 | 20061832 | 1.63 | 68.4 | Palliative (P) | 2016-12-10 | 2016-12-24 | Gemcitabine + Capecitabine | 2 | N | CAPECITABINE + GEMCITABINE | 101117386 |
| 20160440 | 20061833 | 1.82 | 69.3 | Neo-adjuvant (N) | 2016-10-19 | 2016-11-09 | ECX | 02 | null | ECX | 101571835 |
| 20160442 | 20061834 | 1.56 | 63.2 | Palliative (P) | 2016-03-31 | 2016-04-14 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101795066 |
| 20160443 | 20061835 | 1.46 | 66.75 | Neo-adjuvant (N) | 2018-11-23 | 2018-12-21 | ECX | N | N | ECX | 100312241 |
| 20160446 | 20061836 | 1.86 | 70 | Palliative (P) | 2016-09-25 | 2016-10-09 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101430452 |
| 20160447 | 20061837 | 1.72 | 92.4 | Neo-adjuvant (N) | 2019-05-06 | 2019-05-17 | ECX | 02 | N | ECX | 100639636 |
| 20160449 | 20061838 | 1.81 | 88.9 | Adjuvant (A) | 2019-02-07 | 2019-02-13 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100752021 |
| 20160450 | 20061839 | 1.82 | 55.3 | Neo-adjuvant (N) | 2017-04-09 | 2017-04-26 | ECX | N | N | ECX | 101512076 |
| 20160451 | 20061840 | 1.71 | 56.8 | Palliative (P) | 2017-03-05 | 2017-03-26 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101205605 |
| 20160452 | 20061841 | 1.62 | 76 | Neo-adjuvant (N) | 2017-10-02 | 2017-10-05 | ECX | N | null | ECX | 100803825 |
| 20160456 | 20061842 | 1.64 | 46.2 | null | 2018-12-09 | 2018-12-26 | Gemcitabine + Capecitabine | N | null | CAPECITABINE + GEMCITABINE | 100277461 |
| 20160458 | 20061843 | 1.74 | 51.7 | Palliative (P) | 2017-08-06 | 2017-08-17 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100543035 |
| 20160459 | 20061844 | 1.65 | 84.5 | Neo-adjuvant (N) | 2018-03-15 | 2018-03-31 | ECX | N | N | ECX | 100896704 |
| 20160461 | 20061845 | 1.66 | 114 | Adjuvant (A) | 2019-09-22 | 2019-10-01 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100644754 |
| 20160462 | 20061846 | 1.57 | 50 | Curative (C) | 2016-06-28 | 2016-07-12 | ECX | 02 | N | ECX | 101621863 |
| 20160463 | 20061847 | 1.8 | 51 | Curative (C) | 2019-10-30 | 2019-10-30 | ECX | 02 | N | ECX | 101228123 |
| 20160464 | 20061848 | 1.76 | 78.7 | Neo-adjuvant (N) | 2019-11-28 | 2019-11-28 | ECX | 2 | N | ECX | 101521882 |
| 20160466 | 20061849 | 1.79 | 53.55 | null | 2018-07-10 | 2018-07-19 | ECX | N | N | ECX | 100655666 |
| 20160467 | 20061850 | 1.69 | 96.9 | Neo-adjuvant (N) | 2016-04-02 | 2016-04-09 | ECX | 02 | N | ECX | 100469360 |
| 20160469 | 20061851 | 1.68 | 81 | Neo-adjuvant (N) | null | 2016-02-12 | ECX | null | N | ECX | 101722818 |
| 20160471 | 20061852 | 1.46 | 107.8 | Neo-adjuvant (N) | 2016-12-15 | 2016-12-19 | ECX | 02 | N | ECX | 101202970 |
| 20160473 | 20061853 | 1.72 | 68.4 | Adjuvant (A) | 2017-10-02 | 2017-10-06 | CAPECITABINE + GEMCITABINE | N | N | CAPECITABINE + GEMCITABINE | 100846550 |
| 20160474 | 20061854 | 1.69 | 68.95 | Neo-adjuvant (N) | 2019-04-23 | 2019-05-07 | ECX | N | N | ECX | 100218005 |
| 20160478 | 20061855 | 1.8 | 92 | null | 2016-03-19 | 2016-03-19 | ECX | N | N | ECX | 101014493 |
| 20160479 | 20061856 | 1.61 | 65 | Neo-adjuvant (N) | 2018-06-19 | 2018-06-30 | ECX | 2 | N | ECX | 101082400 |
| 20160480 | 20061857 | 1.67 | 95.4 | Adjuvant (A) | 2018-10-07 | 2018-10-18 | ECX | N | N | ECX | 100955741 |
| 20160482 | 20061858 | 1.59 | 86.5 | Neo-adjuvant (N) | 2019-07-21 | 2019-07-25 | ECX | N | N | ECX | 100683590 |
| 20160483 | 20061859 | 1.64 | 61.6 | Adjuvant (A) | 2017-06-03 | 2017-06-19 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100584018 |
| 20160486 | 20061860 | 1.6 | 67.8 | Neo-adjuvant (N) | 2018-04-14 | 2018-05-06 | ECX | 2 | N | ECX | 101519218 |
| 20160487 | 20061861 | 1.72 | 76 | Neo-adjuvant (N) | 2017-10-20 | 2017-10-24 | ECX | 02 | N | ECX | 100832391 |
| 20160489 | 20061862 | 1.73 | null | Palliative (P) | 2016-05-20 | 2016-06-16 | ECX | N | N | CAPECITABINE + GEMCITABINE | 101209060 |
| 20160490 | 20061863 | 1.59 | 64.4 | Curative (C) | null | 2018-05-28 | ECX | N | N | ECX | 101746148 |
| 20160495 | 20061864 | 1.47 | 62.9 | Palliative (P) | 2019-12-02 | 2019-12-27 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100158557 |
| 20160497 | 20061865 | 1.69 | 68 | Neo-adjuvant (N) | 2018-04-06 | 2018-04-10 | ECX | 02 | N | ECX | 101109413 |
| 20160499 | 20061866 | 1.67 | 58.9 | Palliative (P) | 2017-10-28 | 2017-10-28 | ECX | N | N | ECX | 100530733 |
| 20160501 | 20061867 | 1.71 | 82.5 | Neo-adjuvant (N) | 2016-07-31 | 2016-07-31 | ECX | 02 | null | ECX | 100049520 |
| 20160503 | 20061868 | 1.74 | 78.6 | Palliative (P) | 2018-09-06 | 2018-09-27 | ECX | N | N | ECX | 100740667 |
| 20160504 | 20061869 | 1.54 | 101.2 | Palliative (P) | 2016-12-17 | 2016-12-27 | Gemcitabine + Capecitabine | 2 | N | CAPECITABINE + GEMCITABINE | 100064776 |
| 20160506 | 20061870 | 1.78 | 49.6 | Neo-adjuvant (N) | null | 2016-06-28 | ECX | Y | N | ECX | 100729684 |
| 20160508 | 20061871 | null | null | null | 2016-10-26 | 2016-11-01 | ECX | N | N | ECX | 100589339 |
| 20160512 | 20061872 | 1.57 | 60.1 | Neo-adjuvant (N) | 2016-03-07 | 2016-03-07 | ECX | 02 | N | ECX | 101018247 |
| 20160516 | 20061873 | 1.76 | 111 | Neo-adjuvant (N) | 2019-12-18 | 2019-12-21 | ECX | N | N | ECX | 100321486 |
| 20160517 | 20061874 | 1.7 | 62.6 | Neo-adjuvant (N) | 2018-09-24 | 2018-09-30 | ECX | N | N | ECX | 100208762 |
| 20160519 | 20061875 | 1.62 | 44.9 | Palliative (P) | 2018-04-05 | 2018-04-08 | ECX | null | N | ECX | 100177105 |
| 20160520 | 20061876 | 1.8 | 81.6 | Neo-adjuvant (N) | 2018-10-22 | 2018-11-03 | ECX | N | N | ECX | 100156435 |
| 20160521 | 20061877 | 1.73 | 79.3 | Palliative (P) | 2016-12-12 | 2016-12-22 | CAPECITABINE + GEMCITABINE | 2 | N | CAPECITABINE + GEMCITABINE | 101069346 |
| 20160522 | 20061878 | 1.75 | 90.3 | Palliative (P) | 2019-04-23 | 2019-04-27 | ECX | N | N | ECX | 101304041 |